CKI 7 Dihydrochloride: Precision Tool for Casein Kinase 1 Pathway Research

Principle and Setup: Unlocking the Power of Selective CK1 Inhibition

Casein kinase 1 (CK1) is a serine/threonine protein kinase central to numerous cellular processes, including circadian rhythm regulation, Wnt signaling, and DNA repair. Precise modulation of CK1 activity is critical for elucidating its roles in health and disease, especially in cancer biology and neurological disorders. CKI 7 dihydrochloride (N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide dihydrochloride) is a highly selective, cell-permeable CK1 inhibitor for signaling pathway research, offering researchers a reliable means to probe CK1-mediated phosphorylation events in vitro and in cellular models.

With a molecular weight of 358.67 and impressive solubility (up to 17.93 mg/ml in DMSO), CKI 7 dihydrochloride is engineered for experimental flexibility. Sourced from APExBIO, its consistent purity and stability (when stored at -20°C) make it ideal for routine and advanced studies in protein phosphorylation inhibition, pathway modulation, and functional cell biology assays.

Step-by-Step Experimental Workflow: Maximizing CKI 7 Dihydrochloride’s Potential

1. Reagent Preparation and Handling

• Stock Solution: Dissolve CKI 7 dihydrochloride in DMSO to a maximum concentration of 17.93 mg/ml. For aqueous applications, dissolve up to 7.17 mg/ml in water. Prepare fresh solutions for each experiment due to limited solution stability.
• Storage: Store powder at -20°C. Avoid repeated freeze-thaw cycles and long-term storage of solutions to preserve activity.

2. Assay Selection and Application

• Kinase Activity Assays: Use CKI 7 dihydrochloride to inhibit CK1 in in vitro kinase reactions or cell extracts, examining downstream phosphorylation changes.
• Cell-Based Pathway Modulation: Treat cultured cells (e.g., NSCLC, HEK293, U2OS) at empirically determined concentrations (0.5–10 μM commonly used) to assess CK1 pathway involvement in cellular phenotypes such as migration, apoptosis, or circadian gene expression.
• Apoptosis Assays Using CK1 Inhibitors: Integrate CKI 7 dihydrochloride in caspase activation or annexin V/PI staining protocols to evaluate the impact of CK1 inhibition on programmed cell death, especially in cancer biology research contexts.
• Wnt Signaling Pathway Analysis: Apply the inhibitor to dissect the role of CK1 in β-catenin stabilization and nuclear translocation, using luciferase reporter assays or immunoblotting for pathway components.

3. Controls and Experimental Design

• Include vehicle (DMSO) controls and, where possible, orthogonal CK1 inhibitors or genetic knockdown approaches for validation.
• For time-course studies, optimize inhibitor exposure (1–24 hours) based on pathway turnover and cell type sensitivity.

Advanced Applications and Comparative Advantages

Dissecting Cancer Metastasis Pathways with CKI 7 Dihydrochloride

Recent breakthroughs highlight the interplay between kinases and intermediate filament proteins in tumor progression. A 2026 study published in the International Journal of Biological Macromolecules (Luo et al., 2026) elucidated how phosphorylation-dependent ubiquitination of keratin 16, regulated by mitogen-activated protein kinase 10 (MAPK10), suppresses non-small cell lung cancer (NSCLC) metastasis. While MAPK10’s direct action was the focus, CK1’s established role in Wnt signaling and keratin regulation positions CKI 7 dihydrochloride as a strategic tool for complementary studies. Researchers can use CKI 7 to probe whether CK1-mediated phosphorylation events similarly influence keratin stability, protein interactions, or metastatic potential, thereby extending the findings of Luo et al. to new regulatory layers.

Circadian Rhythm Regulation Studies

CKI 7 dihydrochloride’s specificity for CK1 makes it indispensable for circadian biology. CK1δ/ε are core components of the molecular clock, phosphorylating PER proteins and modulating period length. Application of CKI 7 in cell or tissue models allows researchers to temporally control clock protein phosphorylation, measure oscillatory gene expression, and test candidate chronotherapeutics. Compared to less selective kinase inhibitors, CKI 7 offers cleaner data with reduced off-target effects.

Wnt Signaling Pathway Dissection

CK1 acts at multiple nodes in the Wnt pathway—both promoting and attenuating β-catenin signaling. Using CKI 7 dihydrochloride in luciferase reporter assays or immunofluorescence of β-catenin localization enables high-resolution mapping of pathway dynamics. This is particularly relevant in cancer stem cell research, where Wnt signaling governs proliferation and differentiation.

Comparative Advantage: Why Choose CKI 7 Dihydrochloride from APExBIO?

• Potency and Selectivity: Engineered for high affinity and minimal cross-reactivity with other kinases, CKI 7 ensures reproducible, interpretable results.
• Formulation Versatility: Superior solubility in DMSO and water streamlines integration into diverse assay systems.
• Quality Assurance: APExBIO’s rigorous quality control and cold-chain shipping (on blue ice) protect compound integrity, a critical factor for kinase inhibitor studies.

Interlinking Related Knowledge

• Casein kinase 1’s role in Wnt/β-catenin regulation (Nature Communications): This article complements CKI 7 dihydrochloride’s application by providing mechanistic insights into CK1’s direct targets in cancer.
• CK1 inhibitors in circadian rhythm modulation (Frontiers in Neuroscience): Extends the utility of CKI 7 for chronobiology, highlighting translational models.
• Comparative analysis of kinase inhibitors in apoptosis assays (Cell Reports Medicine): Contrasts CKI 7’s selectivity with broad-spectrum inhibitors, underscoring the product’s value in apoptosis research.

Troubleshooting and Optimization Tips

• Solubility Issues: If precipitation is observed at higher concentrations, gently warm the DMSO stock to 37°C and vortex. Avoid exceeding manufacturer-recommended concentrations to prevent compound aggregation.
• Cell Toxicity: Excessive CK1 inhibition can cause off-target stress or cell death, particularly in sensitive lines. Begin with low micromolar doses and titrate upwards, monitoring viability via MTT or ATP assays.
• Off-Target Effects: Validate pathway specificity by using genetic CK1 knockdown controls or employing rescue experiments with CK1-insensitive pathway variants.
• Batch Variability: Always confirm compound lot number and source (APExBIO) in publications to ensure reproducibility.
• Phosphorylation Readouts: For protein phosphorylation inhibition studies, use phospho-specific antibodies and normalize to total protein levels to control for changes in protein expression or loading.

Future Outlook: Expanding the Impact of CKI 7 Dihydrochloride in Biomedical Research

As the molecular landscape of disease grows increasingly complex, highly selective tools like CKI 7 dihydrochloride will be pivotal for pathway-centric therapeutic discovery. Ongoing studies are poised to unravel CK1’s nuanced contributions in neurodegeneration, metabolic disorders, and immuno-oncology. Integrating CKI 7 into multi-omics and high-content screening workflows will further illuminate context-dependent effects and support the development of precision therapies.

Building on foundational work such as the MAPK10/KRT16 axis in NSCLC metastasis (Luo et al., 2026), CKI 7 dihydrochloride offers researchers the means to interrogate kinase networks at the interface of cell signaling and protein homeostasis. Its robust performance and trusted supply chain from APExBIO ensure that labs worldwide can confidently advance their discoveries in cancer, circadian rhythm, and beyond.